Arguelles ZA, Infante AA, Chong LA, Chao PC

Language: Spanish
References: 9
Page: 38-42
PDF size: 150.59 Kb.

ABSTRACT

IgG4 - related disease is characterized by inflammatory fibrosis accompanied by elevated IgG4 serum concentrations. Clinically it can show involvement of one or multiple organs. It has been considered that this disease is secondary to the interaction between Th2 cells and B cells, which results in high concentrations of IgG4 and inflammatory mediators subsequent to lymphoplasmacytic infiltrates and fibrosis. However, it is not the only mechanism involved. For the diagnosis, clinical, serological, histopathological and immunohistochemical criteria are required. Good response to steroid treatment has been observed. We report the case of a 30-year-old woman with recurrent pleural effusion, interstitial lung disease, impaired progressive renal function, and elevation of parathyroid hormone and calcium in the blood. The studies revealed high serum levels of IgG4, lung and kidney biopsy consistent with IgG4-related disease. The patient was treated with 40 mg prednisone a day with excellent response.

REFERENCES

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl JMed. 2012;366:539- 51.

2. Umehara H. Comprehensive diagnostic criteria forIgG4-related disease. Mod Rheumatol. 2011;22:21-30.

3. Erlij D, Ramos D, Montaña J, Kusnir P, Correa G, Neira Óscar. Enfermedad relacionada a IgG4, el nuevo "gran simulador": caso clínico presentación de un caso. Rev Med Chile. 2014;142:646-50.

4. Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International Consensus Guidance Statement on the Managementa Treatment IgG4- Related Disease. Ann Rheum. 2015;67(7):1688-99.

5. Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: The Mayo Clinic experience. Gut. 2013;62:1607-15.

6. Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: Dataset of 235 consecutive patients. Medicine. 2015;94:680.

7. Yamamoto M, Awakawa T, Takahashi H. Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years. Ann Rheum Dis. 2015;74:46.

8. Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4related disease: Clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67:2466-75.

9. Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD Int J Rheumatol. 2012;12-25.